Thank you, Dr. Turner, for your inspiring leadership and dedication to advocacy! ⁦Patricia L. Turner, MD, MBA, FACS⁩ ⁦American College of Surgeons⁩

Excellent overview of the current state of neoadjuvant systemic therapy in down-staging axillary management and where we are headed in the future by Sarah McLaughlin (No, she will never get a X handle).

Thanks Olga Kantor MD, MS, FACS! Shifting our focus to UNDERtreament of older adults here. Certainly need qualitative data to unveil why some of our most vulnerable pt populations are not getting guideline-concordant care. Fun #ASBRS24 with the Brigham and Women’s Department of Surgery crew.

🕘The clock is ticking to register for the last webinar of our GI series happening on Tuesday to discover the 🗝️ to revolutionizing gastric cancer care & establish/enhance a multidisciplinary tumor board to optimize patient outcomes.

Register now: ow.ly/JW2V50Rf5l2

Chandler S Cortina, MD with his pioneering work in incorporating risk assessment in gender affirming chest wall masculinization surgery to ensure appropriate risk stratification and consideration of involving a breast surgeon in those at high risk MCW Surgery #ASBrS24

🙏 Thank you for bringing the much needed patient voice/perspective! #BetterTogether

For neoadjuvant endocrine therapy we first turn to the ACOSOG-Z1031 trial. NAET can inform decisions on adjuvant chemotherapy in synergy with genomic testing! #Asbrs24

.Anna Weiss presenting GET FACTS RCT on quantitative genetic counseling showing pts better estimate CBC risk yet still higher than actual risk and it doesn’t change CPM rates. Seems as if other factors drive CPM decisions #ASBrS24 ASBrS

Personalized radiation by Julia White at #ASBRS24 !!

Such important work!!👇👇👇

Congratulations, 🎉 Judy Boughey. 👏 looking forward to another great year ASBrS!

Our future is looking bright! Wonderful engagement in our fellows lounge. #ASBrS24 #MedEd

Anna Weiss showing improved pt understanding of CBC risk after quantitative genetic counseling but ultimately didn’t impact their decision for CPM. ASBrS #ASBrS24

Very interesting study by Anna Weiss regarding genetic testing for surgical decision making. We need to change the way we test as we increase the number of patients tested and assure our patients really understand their future risks of contralateral cancer. #asbrs24 ASBrS

👏 👏 👏 Chandler S Cortina, MD!! #ASBrS24

The ASBrS is in wonderful hands with Judy Boughey at the helm for 2024-25😀ASBrS

Robby Pride is on the map! 🗺️📍

So fun catching up with Mass General Surgery Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center residents,fellows, and faculty past and present! Proud of our fellows and our training program ❤️🌟 Society of Surgical Oncology ASBrS

Dr. Sara Myers of Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center presents on the association of arm morbidity and financial difficulty — with 70% of patients reporting the highest financial impact of breast cancer treatment having severe arm symptoms Laura Dominici MD Dr. E Mittendorf Tari King MD

Amazing Brigham and Women’s Department of Surgery resident and future breast surgeon Eliza Hersh Lorentzen, MD presents her work on disparities in omission of surgery in older women with high risk breast cancer - age >85, black race, and poor/no insurance associated with omission of surgery #ASBrS24